Document:USA 42 CFR Part 11 09-Apr-2025: Difference between revisions
From GxPlex
Gxplex admin (talk | contribs) m 1 revision imported |
Migrate to Template:DocumentData for PageForms (GxPlexBot) |
||
| Line 1: | Line 1: | ||
{{DocumentData | |||
Ā | |||
|reference=USAĀ 42 CFR Part 11Ā 09-Apr-2025 | |reference=USAĀ 42 CFR Part 11Ā 09-Apr-2025 | ||
|validity_area=USA | |validity_area=USA | ||
Revision as of 12:54, 16 July 2026
| Document information | |
|---|---|
| Reference | USA 42 CFR Part 11 09-Apr-2025 |
| Validity area | USA |
| Scope(s) | G |
| Document name | 42 CFR Part 11 |
| Version / Revision | 09-Apr-2025 |
| Status | Current |
| Document type | Legal act |
| Language(s) | EN |
| Description | Title 42āPublic Health
Chapter IāPublic Health Service, Department of Health and Human Services Subchapter AāGeneral Provisions Part 11 Clinical Trials Registration and Results Information Submission https://www.ecfr.gov/current/title-42 |
| Official source | Official link |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
References
| Scope | Document part | Language | Preview | |
|---|---|---|---|---|
| USA 42 CFR Part 11 09-Apr-2025 Ā§ 11.10 (b) (5) | G | Ā§ 11.10 (b) (5) | EN | (5) Study Design means a description of the manner in which the clinical trial will be conducted, including the following information: (i) Interventiā¦ |
| USA 42 CFR Part 11 09-Apr-2025 Ā§ 11.24 | G | Ā§ 11.24 | EN | Ā§ 11.24 When must clinical trial registration information be submitted? (a) General. Except as provided in paragraph (b) of this section, the responsā¦ |
| USA 42 CFR Part 11 09-Apr-2025 Ā§ 11.4 | G | Ā§ 11.4 | EN | Ā§ 11.4 To whom does this part apply?
[ā¦] (c) Determination of responsible party. For purposes of this part, each applicable clinical trial or other clā¦ |
| USA 42 CFR Part 11 09-Apr-2025 Ā§ 11.40 | G | Ā§ 11.40 | EN | Ā§ 11.40 Who must submit clinical trial results information? The responsible party for an applicable clinical trial specified in Ā§ 11.42 must submit clā¦ |
| USA 42 CFR Part 11 09-Apr-2025 Ā§ 11.44 | G | Ā§ 11.44 | EN | Ā§ 11.44 When must clinical trial results information be submitted for applicable clinical trials
subject to Ā§ 11.42? (a) Standard submission deadline.ā¦ |
| USA 42 CFR Part 11 09-Apr-2025 Ā§ 11.54 | G | Ā§ 11.54 | EN | Ā§ 11.54 What are the procedures for requesting and obtaining a waiver of the requirements for clinical trial results information submission? [ā¦]ā¦ |
| USA 42 CFR Part 11 09-Apr-2025 Ā§ 11.6 | G | Ā§ 11.6 | EN | Ā§ 11.6 What are the requirements for the submission of truthful information? The clinical trial information submitted by a responsible party under thiā¦ |
| USA 42 CFR Part 11 09-Apr-2025 Ā§ 11.64 | G | Ā§ 11.64 | EN | Ā§ 11.64 When must clinical trial information submitted to ClinicalTrials.gov be updated or corrected?
(a) Updates. [ā¦] (b) Correctionsā [ā¦]ā¦ |
| USA 42 CFR Part 11 09-Apr-2025 Ā§ 11.8 | G | Ā§ 11.8 | EN | Ā§ 11.8 In what format must clinical trial information be submitted? Information submitted under this part must be submitted electronically to Clinicalā¦ |
References
| Reference | Scope | Document part | Language | Preview |
|---|---|---|---|---|
| Reference:USA 42 CFR Part 11 09-Apr-2025 Ā§ 11.4 | G | Ā§ 11.4 | EN | Ā§ 11.4 To whom does this part apply? [ā¦] (c) Determination of responsible party. For purposes of this part, each applicable clinical trial or other clinical trial must have one responsible party. ... |
| Reference:USA 42 CFR Part 11 09-Apr-2025 Ā§ 11.6 | G | Ā§ 11.6 | EN | Ā§ 11.6 What are the requirements for the submission of truthful information? The clinical trial information submitted by a responsible party under this part shall not be false or misleading in any ... |
| Reference:USA 42 CFR Part 11 09-Apr-2025 Ā§ 11.8 | G | Ā§ 11.8 | EN | Ā§ 11.8 In what format must clinical trial information be submitted? Information submitted under this part must be submitted electronically to ClinicalTrials.gov, in the format specified at ... |
| Reference:USA 42 CFR Part 11 09-Apr-2025 Ā§ 11.24 | G | Ā§ 11.24 | EN | Ā§ 11.24 When must clinical trial registration information be submitted? (a) General. Except as provided in paragraph (b) of this section, the responsible party for an applicable clinical trial for ... |
| Reference:USA 42 CFR Part 11 09-Apr-2025 Ā§ 11.64 | G | Ā§ 11.64 | EN | Ā§ 11.64 When must clinical trial information submitted to ClinicalTrials.gov be updated or corrected? (a) Updates. [ā¦] (b) Correctionsā [ā¦] |
| Reference:USA 42 CFR Part 11 09-Apr-2025 Ā§ 11.10 (b) (5) | G | Ā§ 11.10
(b) (5) || EN || (5) Study Design means a description of the manner in which the clinical trial will be conducted, including the following information: (i) Interventional Study Model. The strategy for assigning ... | ||
| Reference:USA 42 CFR Part 11 09-Apr-2025 Ā§ 11.40 | G | Ā§ 11.40 | EN | Ā§ 11.40 Who must submit clinical trial results information? The responsible party for an applicable clinical trial specified in Ā§ 11.42 must submit clinical trial results information for that ... |
| Reference:USA 42 CFR Part 11 09-Apr-2025 Ā§ 11.44 | G | Ā§ 11.44 | EN | Ā§ 11.44 When must clinical trial results information be submitted for applicable clinical trials subject to Ā§ 11.42? (a) Standard submission deadline. In general, for applicable clinical trials ... |
| Reference:USA 42 CFR Part 11 09-Apr-2025 Ā§ 11.54 | G | Ā§ 11.54 | EN | Ā§ 11.54 What are the procedures for requesting and obtaining a waiver of the requirements for clinical trial results information submission? [ā¦] |
